Medivir AB (publ) (Nasdaq Stockholm) has completed a share redemption offering of approx. SEK 870 million to Medivir’s shareholders.
The Vinge team was headed by capital markets and public M&A partner Erik Sjöman and included Rikard Lindahl and Malte Hedlund.
